Shares in Accuray (NSDQ:ARAY) fell slightly today after the medical device maker posted fiscal year 2019 third quarter earnings that beat loss-per-share expectations but missed revenue consensus on Wall Street. The Sunnyvale, Calif.-based company posted losses of $1.2 million, or 1¢ per share, on sales of $103.2 million for the three months ended March 31, seeing […]
Accuray partners with Chinese company to sell in China
A subsidiary of California-based Accuray (NSDQ:ARAY) has entered a joint venture with a Chinese company to manufacture and sell radiology oncology systems in China, the companies said today. Accuray Asia Ltd. will work with Tianjin-based CNNC High Energy Equipment, a subsidiary of China Isotope and Radiation (HKSE:01763). CNNC will own 51% of the joint venture, known as CNNC […]
Accuray’s fiscal Q2 earnings top expectations despite sales miss
Accuray (NSDQ:ARAY) this week posted fiscal second-quarter earnings that beat the consensus on Wall Street but missed sales expectations. The Sunnyvale, Calif.-based company put up losses of -$4.6 million, or -5¢ per share, on sales of $102.3 million for the three months ended YYdate, paring its losses by -1.7% on sales growth of 2.0% compared with […]
Senseonics CFO Elsey to retire | Personnel Moves – December 4, 2018
Senseonics (NYSE:SENS) said yesterday that its CFO R. Elsey is retiring for the company, and that it has begun searching for a permanent replacement. The Germantown, Md.-based company said that Elsey will stay on until a replacement is appointed, and remain on in an advisory role through to the completion of the company’s 2018 fiscal […]
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]
Accuray posts mixed bag FY2019 Q1 earnings
Accuray (NSDQ:ARAY) today released fiscal year first quarter earnings that beat Wall Street expectations for sales, but missed on loss-per-share consensus. The Sunnyvale, Calif.-based company posted losses of $9.2 million, or 11¢ per share, on sales of $95.8 million for the three months ended September 30, seeing losses shrink 1.9% while sales grew 5.4% when compared […]
These 10 medtech companies care a lot about research
These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal […]
Accuray touts high survival rate, low toxicity in Cyberknife studies
Accuray (NSDQ:ARAY) today released data from two studies of its CyberKnife stereotactic body radiotherapy device exploring its use in treating patients with low and intermediate-risk prostate cancer, touting high survival rates and minimal toxicity. The Sunnyvale, Calif.-based company touted the studies as the largest conducted to date evaluating stereotactic body radiation therapy in patients with localized […]
Accuray shares rise on Street-topping Q4, FY2018 earnings
Shares in Accuray (NSDQ:ARAY) rose today after the medical device maker beat expectations on Wall Street with its fourth quarter and full fiscal year 2018 earnings. The Sunnyvale, Calif.-based company posted losses of $946,000 or 1¢ per share, on sales of $113.8 million for the three months ended June 30, seeing losses shrink 82% while sales […]
7 medtech stories we missed this week: June 22, 2018
From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in […]
Accuray shares down on Q3 EPS miss, growing losses
Shares in Accuray (NSDQ:ARAY) have fallen today after the medical device maker missed EPS expectations on Wall Street with its fiscal year 2018 third quarter earnings results. The Sunnyvale, Calif.-based company posted losses of $8.9 million, or 10¢ per share, on sales of $99.8 million for the three months ended March 31, seeing losses grow 76% […]
- 1
- 2
- 3
- …
- 11
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube